Published in Health Business Week, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Prana Biotechnology.
Report 1: Prana Biotechnology Limited (PRAN, PBT), in compliance with NASDAQ Marketplace Rule IM-4350-6, announced that the company's independent registered public accountants included a going concern explanatory paragraph in its report on Prana Biotechnology's consolidated financial statements as of and for the fiscal year ended June 30, 2006, contained in the company's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.